- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Loading...
Torrent Pharmaceuticals has announced a board meeting on key decisions including approval of the financial results for the quarter and half-year. Consolidated revenue grew 7% YoY to ₹11,516 Cr, with net profit rising 15% to ₹1,911 Cr. India led growth with a 13% revenue jump to ₹6,393 Cr, driven by chronic therapies. US and Europe markets showed moderate gains, while Brazil was hit by currency weakness. A final dividend of ₹6/share follows an interim of ₹26/share. Aman Mehta will take over as Managing Director from August 1, 2025.